Individual Study / CanCOLD

Canadian Cohort of Obstructive Lung Disease
  1. Home
  2. Individual Studies
  3. CanCOLD

Canadian Cohort of Obstructive Lung Disease

CanCOLD logo
Networks -
Datasets -
Variables -
Start Year
2009
Visit CanCOLD
Add to cart

Members

Download
Investigators Contacts
  • Dr. Jean Bourbeau
    McGill University
  • Dr. Wan Tan
    British Columbia University
  • Dr. Jean Bourbeau
    McGill University

Design

Study design
Cohort
Follow Up
Participants were followed-up every 18 months (in-site) after the baseline visit and quarterly (via telephone) starting in July 2012.

Marker Paper

Bourbeau J, Tan WC, Benedetti A, et al., Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the Need for Longitudinal Observational Studies in COPD. COPD. 2012 Mar 20.

PUBMED 22433011

Recruitment

Recruitment Target
  • Individuals

Number of Participants

Number of Participants
1,561
Number of Participants with Biological Samples
1,386
Supplementary Information
COPD moderate-severe: 346 participants
COPD mild: 486 participants
At risk: 422 participants
Healthy controls: 307 participants

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other
Yes
No
Not applicable
Don't know

Timeline

Populations

Selection Criteria
Minimum age
40
Newborns
Twins
Countries
  • Canada
Territory
Montréal, Vancouver, Calgary, Halifax, Toronto, Ottawa, Kingston, Québec, Saskatoon
Ethnic Origin
Health Status
  • With moderate to severe COPD (GOLD 2-4)
Other Criteria
The subjects have to live near one of the study site

Recruitment

Sources of recruitment
  • General population
  • Participants from existing studies
General Population
  • Random digit dialing
Participants from Existing Studies
  • The Canadian Obstructive Lung Disease (COLD) prevalence study

Number of Participants

Number of Participants
346
Number of Participants with Biological Samples
308
Data Collection Events
# Name Description Start End
0 CanCOLD - COPD moderate-severe - Baseline Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2009-11 2015-08
1 CanCOLD - COPD moderate-severe - 18 months Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2011-06 2015-11
2 CanCOLD - COPD moderate-severe - Quarterly follow-up 1 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2012-07 2012-07
3 CanCOLD - COPD moderate-severe - Quarterly follow-up 2 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2012-10 2012-10
4 CanCOLD - COPD moderate-severe - 36 months Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2013-01 2019-08
5 CanCOLD - COPD moderate-severe - Quarterly follow-up 3 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-01 2013-01
6 CanCOLD - COPD moderate-severe - Quarterly follow-up 4 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-04 2013-04
7 CanCOLD - COPD moderate-severe - Quarterly follow-up 5 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-07 2013-07
8 CanCOLD - COPD moderate-severe - Quarterly follow-up 6 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-10 2013-10
9 CanCOLD - COPD moderate-severe - Quarterly follow-up 7 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-01 2014-01
10 CanCOLD - COPD moderate-severe - Quarterly follow-up 8 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-04 2014-04
11 CanCOLD - COPD moderate-severe - Quarterly follow-up 9 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-07 2014-07
12 CanCOLD - COPD moderate-severe - Quarterly follow-up 10 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-10 2014-10
13 CanCOLD - COPD moderate-severe - Quarterly follow-up 11 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-01 2015-01
14 CanCOLD - COPD moderate-severe - Quarterly follow-up 12 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-04 2015-04
15 CanCOLD - COPD moderate-severe - Quarterly follow-up 13 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-07 2015-07
16 CanCOLD - COPD moderate-severe - Quarterly follow-up 14 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-10 2015-10
17 CanCOLD - COPD moderate-severe - Quarterly follow-up 15 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-01 2016-01
18 CanCOLD - COPD moderate-severe - Quarterly follow-up 16 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-04 2016-04
19 CanCOLD - COPD moderate-severe - Quarterly follow-up 17 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-07 2016-07
20 CanCOLD - COPD moderate-severe - Quarterly follow-up 18 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-10 2016-10
21 CanCOLD - COPD moderate-severe - Quarterly follow-up 19 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-01 2017-01
22 CanCOLD - COPD moderate-severe - Quarterly follow-up 20 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-04 2017-04
23 CanCOLD - COPD moderate-severe - Quarterly follow-up 21 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-07 2017-07
24 CanCOLD - COPD moderate-severe - Quarterly follow-up 22 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-10 2017-10
25 CanCOLD - COPD moderate-severe - Quarterly follow-up 23 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-01 2018-01
26 CanCOLD - COPD moderate-severe - Quarterly follow-up 24 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-04 2018-04
27 CanCOLD - COPD moderate-severe - Quarterly follow-up 25 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-07 2018-07
28 CanCOLD - COPD moderate-severe - Quarterly follow-up 26 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-10 2018-10
29 CanCOLD - COPD moderate-severe - Quarterly follow-up 27 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-01 2019-01
30 CanCOLD - COPD moderate-severe - Quarterly follow-up 28 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-04 2019-04
31 CanCOLD - COPD moderate-severe - Quarterly follow-up 29 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-07 2019-07
32 CanCOLD - COPD moderate-severe - Quarterly follow-up 30 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-10 2019-10
33 CanCOLD - COPD moderate-severe - Quarterly follow-up 31 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-01 2020-01
34 CanCOLD - COPD moderate-severe - Quarterly follow-up 32 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-04 2020-04
35 CanCOLD - COPD moderate-severe - Quarterly follow-up 33 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-07 2020-07
36 CanCOLD - COPD moderate-severe - Quarterly follow-up 34 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-10 2020-10
37 CanCOLD - COPD moderate-severe - 54 months Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2021
38 CanCOLD - COPD moderate-severe - Quarterly follow-up 35 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-01 2021-01
39 CanCOLD - COPD moderate-severe - Quarterly follow-up 36 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-04 2021-04
40 CanCOLD - COPD moderate-severe - Quarterly follow-up 37 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-07 2021-07
41 CanCOLD - COPD moderate-severe - Quarterly follow-up 38 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-10 2021-10
Selection Criteria
Minimum age
40
Newborns
Twins
Countries
  • Canada
Territory
Montréal, Vancouver, Calgary, Halifax, Toronto, Ottawa, Kingston, Québec, Saskatoon
Ethnic Origin
Health Status
  • With mild COPD (GOLD 1)
Other Criteria
The subjects have to live near one of the study site

Recruitment

Sources of recruitment
  • General population
  • Participants from existing studies
General Population
  • Random digit dialing
Participants from Existing Studies
  • The Canadian Obstructive Lung Disease (COLD) prevalence study

Number of Participants

Number of Participants
486
Number of Participants with Biological Samples
433
Data Collection Events
# Name Description Start End
0 CanCOLD - COPD mild - Baseline Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2009-11 2015-08
1 CanCOLD - COPD mild - 18 months Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2011-06 2015-11
2 CanCOLD - COPD mild - Quarterly follow-up 1 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2012-07 2012-07
3 CanCOLD - COPD mild - Quarterly follow-up 2 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2012-10 2012-10
4 CanCOLD - COPD mild - 36 months Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2013-01 2019-08
5 CanCOLD - COPD mild - Quarterly follow-up 3 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-01 2013-01
6 CanCOLD - COPD mild - Quarterly follow-up 4 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-04 2013-04
7 CanCOLD - COPD mild - Quarterly follow-up 5 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-07 2013-07
8 CanCOLD - COPD mild - Quarterly follow-up 6 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-10 2013-10
9 CanCOLD - COPD mild - Quarterly follow-up 7 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-01 2014-01
10 CanCOLD - COPD mild - Quarterly follow-up 8 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-04 2014-04
11 CanCOLD - COPD mild - Quarterly follow-up 9 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-07 2014-07
12 CanCOLD - COPD mild - Quarterly follow-up 10 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-10 2014-10
13 CanCOLD - COPD mild - Quarterly follow-up 11 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-01 2015-01
14 CanCOLD - COPD mild - Quarterly follow-up 12 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-04 2015-04
15 CanCOLD - COPD mild - Quarterly follow-up 13 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-07 2015-07
16 CanCOLD - COPD mild - Quarterly follow-up 14 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-10 2015-10
17 CanCOLD - COPD mild - Quarterly follow-up 15 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-01 2016-01
18 CanCOLD - COPD mild - Quarterly follow-up 16 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-04 2016-04
19 CanCOLD - COPD mild - Quarterly follow-up 17 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-07 2016-07
20 CanCOLD - COPD mild - Quarterly follow-up 18 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-10 2016-10
21 CanCOLD - COPD mild - Quarterly follow-up 19 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-01 2017-01
22 CanCOLD - COPD mild - Quarterly follow-up 20 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-04 2017-04
23 CanCOLD - COPD mild - Quarterly follow-up 21 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-07 2017-07
24 CanCOLD - COPD mild - Quarterly follow-up 22 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-10 2017-10
25 CanCOLD - COPD mild - Quarterly follow-up 23 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-01 2018-01
26 CanCOLD - COPD mild - Quarterly follow-up 24 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-04 2018-04
27 CanCOLD - COPD mild - Quarterly follow-up 25 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-07 2018-07
28 CanCOLD - COPD mild - Quarterly follow-up 26 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-10 2018-10
29 CanCOLD - COPD mild - Quarterly follow-up 27 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-01 2019-01
30 CanCOLD - COPD mild - Quarterly follow-up 28 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-04 2019-04
31 CanCOLD - COPD mild - Quarterly follow-up 29 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-07 2019-07
32 CanCOLD - COPD mild - Quarterly follow-up 30 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-10 2019-10
33 CanCOLD - COPD mild - Quarterly follow-up 31 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-01 2020-01
34 CanCOLD - COPD mild - Quarterly follow-up 32 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-04 2020-04
35 CanCOLD - COPD mild - Quarterly follow-up 33 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-07 2020-07
36 CanCOLD - COPD mild - Quarterly follow-up 34 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-10 2020-10
37 CanCOLD - COPD mild - 54 months Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2021
38 CanCOLD - COPD mild - Quarterly follow-up 35 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-01 2021-01
39 CanCOLD - COPD mild - Quarterly follow-up 36 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-04 2021-04
40 CanCOLD - COPD mild - Quarterly follow-up 37 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-07 2021-07
41 CanCOLD - COPD mild - Quarterly follow-up 38 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-10 2021-10
Selection Criteria
Minimum age
40
Newborns
Twins
Countries
  • Canada
Territory
Montréal, Vancouver, Calgary, Halifax, Toronto, Ottawa, Kingston, Québec, Saskatoon
Ethnic Origin
Health Status
  • With normal post bronchodilator spirometry
Other Criteria
Ever smoker, live near one of the study site

Recruitment

Sources of recruitment
  • General population
  • Participants from existing studies
General Population
  • Random digit dialing
Participants from Existing Studies
  • The Canadian Obstructive Lung Disease (COLD) prevalence study

Number of Participants

Number of Participants
422
Number of Participants with Biological Samples
372
Data Collection Events
# Name Description Start End
0 CanCOLD - At risk - Baseline Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2009-11 2015-08
1 CanCOLD - At risk - 18 months Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2011-06 2015-11
2 CanCOLD - At risk - Quarterly follow-up 1 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2012-07 2012-07
3 CanCOLD - At risk - Quarterly follow-up 2 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2012-10 2012-10
4 CanCOLD - At risk - 36 months Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2013-01 2019-08
5 CanCOLD - At risk - Quarterly follow-up 3 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-01 2013-01
6 CanCOLD - At risk - Quarterly follow-up 4 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-04 2013-04
7 CanCOLD - At risk - Quarterly follow-up 5 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-07 2013-07
8 CanCOLD - At risk - Quarterly follow-up 6 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-10 2013-10
9 CanCOLD - At risk - Quarterly follow-up 7 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-01 2014-01
10 CanCOLD - At risk - Quarterly follow-up 8 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-04 2014-04
11 CanCOLD - At risk - Quarterly follow-up 9 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-07 2014-07
12 CanCOLD - At risk - Quarterly follow-up 10 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-10 2014-10
13 CanCOLD - At risk - Quarterly follow-up 11 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-01 2015-01
14 CanCOLD - At risk - Quarterly follow-up 12 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-04 2015-04
15 CanCOLD - At risk - Quarterly follow-up 13 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-07 2015-07
16 CanCOLD - At risk - Quarterly follow-up 14 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-10 2015-10
17 CanCOLD - At risk - Quarterly follow-up 15 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-01 2016-01
18 CanCOLD - At risk - Quarterly follow-up 16 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-04 2016-04
19 CanCOLD - At risk - Quarterly follow-up 17 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-07 2016-07
20 CanCOLD - At risk - Quarterly follow-up 18 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-10 2016-10
21 CanCOLD - At risk - Quarterly follow-up 19 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-01 2017-01
22 CanCOLD - At risk - Quarterly follow-up 20 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-04 2017-04
23 CanCOLD - At risk - Quarterly follow-up 21 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-07 2017-07
24 CanCOLD - At risk - Quarterly follow-up 22 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-10 2017-10
25 CanCOLD - At risk - Quarterly follow-up 23 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-01 2018-01
26 CanCOLD - At risk - Quarterly follow-up 24 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-04 2018-04
27 CanCOLD - At risk - Quarterly follow-up 25 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-07 2018-07
28 CanCOLD - At risk - Quarterly follow-up 26 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-10 2018-10
29 CanCOLD - At risk - Quarterly follow-up 27 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-01 2019-01
30 CanCOLD - At risk - Quarterly follow-up 28 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-04 2019-04
31 CanCOLD - At risk - Quarterly follow-up 29 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-07 2019-07
32 CanCOLD - At risk - Quarterly follow-up 30 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-10 2019-10
33 CanCOLD - At risk - Quarterly follow-up 31 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-01 2020-01
34 CanCOLD - At risk - Quarterly follow-up 32 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-04 2020-04
35 CanCOLD - At risk - Quarterly follow-up 33 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-07 2020-07
36 CanCOLD - At risk - Quarterly follow-up 34 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-10 2020-10
37 CanCOLD - At risk - 54 months Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2021
38 CanCOLD - At risk - Quarterly follow-up 35 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-01 2021-01
39 CanCOLD - At risk - Quarterly follow-up 36 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-04 2021-04
40 CanCOLD - At risk - Quarterly follow-up 37 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-07 2021-07
41 CanCOLD - At risk - Quarterly follow-up 38 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-10 2021-10
Selection Criteria
Minimum age
40
Newborns
Twins
Countries
  • Canada
Territory
Montréal, Vancouver, Calgary, Halifax, Toronto, Ottawa, Kingston, Québec, Saskatoon
Ethnic Origin
Health Status
  • With normal post bronchodilator spirometry and without respiratory diseases
Other Criteria
Never smoker, live near one of the study site

Recruitment

Sources of recruitment
  • General population
  • Participants from existing studies
General Population
  • Random digit dialing
Participants from Existing Studies
  • The Canadian Obstructive Lung Disease (COLD) prevalence study

Number of Participants

Number of Participants
307
Number of Participants with Biological Samples
273
Data Collection Events
# Name Description Start End
0 CanCOLD - Healthy controls - Baseline Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2009-11 2015-08
1 CanCOLD - Healthy controls - 18 months Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2011-06 2015-11
2 CanCOLD - Healthy controls - Quarterly follow-up 1 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2012-07 2012-07
3 CanCOLD - Healthy controls - Quarterly follow-up 2 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2012-10 2012-10
4 CanCOLD - Healthy controls - 36 months Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2013-01 2019-08
5 CanCOLD - Healthy controls - Quarterly follow-up 3 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-01 2013-01
6 CanCOLD - Healthy controls - Quarterly follow-up 4 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-04 2013-04
7 CanCOLD - Healthy controls - Quarterly follow-up 5 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-07 2013-07
8 CanCOLD - Healthy controls - Quarterly follow-up 6 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2013-10 2013-10
9 CanCOLD - Healthy controls - Quarterly follow-up 7 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-01 2014-01
10 CanCOLD - Healthy controls - Quarterly follow-up 8 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-04 2014-04
11 CanCOLD - Healthy controls - Quarterly follow-up 9 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-07 2014-07
12 CanCOLD - Healthy controls - Quarterly follow-up 10 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2014-10 2014-10
13 CanCOLD - Healthy controls - Quarterly follow-up 11 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-01 2015-01
14 CanCOLD - Healthy controls - Quarterly follow-up 12 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-04 2015-04
15 CanCOLD - Healthy controls - Quarterly follow-up 13 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-07 2015-07
16 CanCOLD - Healthy controls - Quarterly follow-up 14 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2015-10 2015-10
17 CanCOLD - Healthy controls - Quarterly follow-up 15 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-01 2016-01
18 CanCOLD - Healthy controls - Quarterly follow-up 16 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-04 2016-04
19 CanCOLD - Healthy controls - Quarterly follow-up 17 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-07 2016-07
20 CanCOLD - Healthy controls - Quarterly follow-up 18 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2016-10 2016-10
21 CanCOLD - Healthy controls - Quarterly follow-up 19 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-01 2017-01
22 CanCOLD - Healthy controls - Quarterly follow-up 20 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-04 2017-04
23 CanCOLD - Healthy controls - Quarterly follow-up 21 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-07 2017-07
24 CanCOLD - Healthy controls - Quarterly follow-up 22 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2017-10 2017-10
25 CanCOLD - Healthy controls - Quarterly follow-up 23 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-01 2018-01
26 CanCOLD - Healthy controls - Quarterly follow-up 24 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-04 2018-04
27 CanCOLD - Healthy controls - Quarterly follow-up 25 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-07 2018-07
28 CanCOLD - Healthy controls - Quarterly follow-up 26 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2018-10 2018-10
29 CanCOLD - Healthy controls - Quarterly follow-up 27 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-01 2019-01
30 CanCOLD - Healthy controls - Quarterly follow-up 28 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-04 2019-04
31 CanCOLD - Healthy controls - Quarterly follow-up 29 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-07 2019-07
32 CanCOLD - Healthy controls - Quarterly follow-up 30 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2019-10 2019-10
33 CanCOLD - Healthy controls - Quarterly follow-up 31 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-01 2020-01
34 CanCOLD - Healthy controls - Quarterly follow-up 32 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-04 2020-04
35 CanCOLD - Healthy controls - Quarterly follow-up 33 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-07 2020-07
36 CanCOLD - Healthy controls - Quarterly follow-up 34 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2020-10 2020-10
37 CanCOLD - Healthy controls - 54 months Questionnaires were used to collect information on sociodemographic, smoking history and work exposure, consequences of health problems for employment, symptoms and disability; global chest ... 2021
38 CanCOLD - Healthy controls - Quarterly follow-up 35 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-01 2021-01
39 CanCOLD - Healthy controls - Quarterly follow-up 36 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-04 2021-04
40 CanCOLD - Healthy controls - Quarterly follow-up 37 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-07 2021-07
41 CanCOLD - Healthy controls - Quarterly follow-up 38 A 10 minute telephone questionnaire was administered to collect information on COPD exacerbation (i.e. symptom flare-ups). 2021-10 2021-10

Classifications

Socio-demographic and economic characteristics
Lifestyle and behaviours
Birth, pregnancy and reproductive health history
Perception of health, quality of life, development and functional limitations
Diseases
Symptoms and signs
Medication and supplements
Non-pharmacological interventions
Health and community care services utilization
Death
Physical measures and assessments
Laboratory measures
Cognition, personality and psychological measures and assessments
Life events, life plans, beliefs and values
Preschool, school and work life
Social environment and relationships
Physical environment
Administrative information
Cognitive functioning
Personality
Psychological distress and emotions
Other psychological measures and assessments
Perception of health
Quality of life
Life course development
Functional limitations
Other perception of health, quality of life and functional limitation-related information
Tobacco
Alcohol
Drugs
Nutrition
Breastfeeding
Physical activity
Sleep
Sexual behaviours and orientation
Technological devices
Misbehaviour and criminality
Other and unspecified lifestyle information

Socio-demographic and economic characteristics

Age/birthdate
Sex/gender
Marital/partner status
Family and household structure
Education
Residence
Ethnicity, race and religion
Labour force and retirement
Income, possessions, and benefits
Other socio-demographic and economic characteristics

Lifestyle and behaviours

Tobacco
Drugs
Physical activity
Transportation
Sleep

Birth, pregnancy and reproductive health history

Pregnancy, delivery and birth

Perception of health, quality of life, development and functional limitations

Perception of health
Quality of life
Functional limitations

Diseases

Certain infectious and parasitic diseases (A00-B99)
Neoplasms (C00-D48)
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Endocrine, nutritional and metabolic diseases (E00-E90)
Mental and behavioural disorders (F00-F99)
Diseases of the nervous system (G00-G99)
Diseases of the eye and adnexa (H00-H59)
Diseases of the circulatory system (I00-I99)
Diseases of the respiratory system (J00-J99)
Diseases of the digestive system (K00-K93)
Diseases of the musculoskeletal system and connective tissue (M00-M99)
Diseases of the genitourinary system (N00-N99)
Injury, poisoning and certain other consequences of external causes (S00-T98)
Diseases without precise specification or falling into multiple categories

Symptoms and signs

Symptoms and signs involving the circulatory and respiratory systems (R00-R09)
General symptoms and signs (R50-R69)
Symptoms related to multiple categories

Medication and supplements

Medication and supplement intake
Posology and protocol of administration

Non-pharmacological interventions

Surgical interventions
Educational and health promotion interventions
Other and unspecified non-pharmacological interventions

Health and community care services utilization

Visits to health professionals
Hospitalizations
Community and social care

Physical measures and assessments

Anthropometry
Circulation and respiration
Muscles, skeleton and mobility

Laboratory measures

Biochemistry
Genomics

Cognition, personality and psychological measures and assessments

Psychological distress and emotions

Preschool, school and work life

Work life

Social environment and relationships

Social participation
Social support

Physical environment

Housing characteristics
Built environment/neighbourhood characteristics
Workplace characteristics
Chemical exposure
Other physical environment characteristics

Administrative information

Identifiers
Date and time-related information
Questionnaire and interview-related information
Physical and cognitive measure and biosample-related information
Data and sample collection center-related information
Other administrative information

Psychological distress and emotions

Hospital Anxiety and Depression Scale

Quality of life

COPD Assessment Test
EuroQol Visual Analogue Scale
McGill COPD Quality of Life Questionnaire
Short-Form 36 Health Survey
Saint George's Respiratory Questionnaire

Functional limitations

Capacity of Daily Living during the Morning
Morning Activities and Symptoms Questionnaire

Tobacco

Smoking Decisional Balance Scale

Physical activity

Community Healthy Activities Model Program for Seniors Questionnaire

Sleep

Pittsburgh Sleep Quality Index